Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: ANTICORPOS MONOCLONAIS, FARMACOVIGILÂNCIA
ABNT
RODRIGUES, Lara cheliz e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 13 nov. 2024. , 2012APA
Rodrigues, L. cheliz, Ribeiro, A. G., & Kano, E. K. (2012). Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Rodrigues L cheliz, Ribeiro AG, Kano EK. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 27 res. FCF049.[citado 2024 nov. 13 ]Vancouver
Rodrigues L cheliz, Ribeiro AG, Kano EK. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 27 res. FCF049.[citado 2024 nov. 13 ]